US Stock MarketDetailed Quotes

TKPHF TAKEDA PHARMACEUTICAL CO LTD

Watchlist
  • 27.245
  • +0.545+2.04%
15min DelayClose Jul 12 16:00 ET
43.18BMarket Cap47.47P/E (TTM)

TAKEDA PHARMACEUTICAL CO LTD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TAKEDA PHARMACEUTICAL CO LTD Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 9, 2024

Revenue(YoY)

1.05T

+9.91%
EPS(YoY)

-2.01

-110.42%
Analyst Rating

Buy

Jul 13, 2024

TAKEDA PHARMACEUTICAL CO LTD Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q1-- / 1.038T--
May 9, 20242024/Q4-- / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q1-- / 1.038T--
May 9, 20242024/Q4-- / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--

Unlock Free Earnings Estimates

TAKEDA PHARMACEUTICAL CO LTD Earnings Reports

  • 6-K: Corporate Governance Report

    Jul 10 06:09 ET

  • 6-K: 2024 Annual Integrated Report

    Jul 1 06:39 ET

  • 20-F: Registration statement / Annual report / Transition report

    Jun 26 06:13 ET

  • 6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders

    Jun 26 06:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 13, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg